Johnson & Johnson Revenue 2017–2025
Johnson & Johnson annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Johnson & Johnson revenue for the quarter ending March 29, 2026 was 24.1 B, a 9.91% increase year-over-year.
- Johnson & Johnson revenue for the twelve months ending March 29, 2026 was 93.7 B, a 6.89% increase year-over-year.
- Johnson & Johnson annual revenue for 2025 was 94.2 B, a 6.05% increase from 2024.
- Johnson & Johnson annual revenue for 2024 was 88.8 B, a 4.30% increase from 2023.
- Johnson & Johnson annual revenue for 2023 was 85.2 B, a 6.46% increase from 2023.
- Johnson & Johnson annual revenue for 2023 was 80.0 B.
Johnson & Johnson (JNJ) — Frequently Asked Questions
Johnson & Johnson (JNJ) is a publicly traded US company in the Healthcare sector. It has a market capitalization of $579.39B. In fiscal 2025 it reported revenue of $94.19B and net income of $26.80B. Explore JNJ's stock price, financial statements, earnings history, margins and key ratios below.
What is Johnson & Johnson's market cap?
Johnson & Johnson (JNJ) has a market capitalization of $579.39B.
What is the JNJ stock price?
JNJ trades at $238.49 (+0.63% on the day).
How much revenue does Johnson & Johnson make?
Johnson & Johnson reported revenue of $94.19B in fiscal 2025.
Is JNJ profitable?
In fiscal 2025, Johnson & Johnson reported net income of $26.80B.
What is JNJ's P/E ratio?
Based on diluted EPS, JNJ has a price-to-earnings (P/E) ratio of about 21.6.